Pacer Advisors, Inc. Kura Oncology, Inc. Transaction History
Pacer Advisors, Inc.
- $39 Billion
- Q2 2024
A detailed history of Pacer Advisors, Inc. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 709 shares of KURA stock, worth $12,889. This represents 0.0% of its overall portfolio holdings.
Number of Shares
709
Previous 1,451
51.14%
Holding current value
$12,889
Previous $30,000
53.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding KURA
# of Institutions
181Shares Held
80.2MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$129 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$127 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$106 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$98.4 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$82.5 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.22B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...